It boils down to risk v benefits. The under 5s have been relatively very low risk. If a jab can't out do that then there's no room to move forward with that ide

It boils down to risk v benefits. The under 5s have been relatively very low risk. If a jab can't out do that then there's no room to move forward with that idea. Omincron appears to be even less powerful, less of a threat. Those odds make the current jabs even less likely to be approved.